Lobbying Filing Details

Total Spending

$30,000

Activities

3

Lobbyists

1

Gov't Entities

7

Filing Information
Filing UUID:
021bac63-bd8e-43cb-b8eb-a88ce914f4b1
Type:
Q3 - 3rd Quarter - Report
Period:
2024 - 3rd Quarter (July 1 - Sep 30)
Date Posted:
January 20, 2025 at 9:44 PM
Income:
$30,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Steven A. Wolfe
Registrant
CARDINAL POINT PARTNERS

Government Relations

Washington, District of Columbia
Client
TONIX PHARMACEUTICALS, INC.

biotechnology company--pharmaceuticals development and manufacturing

New Jersey, United States of America
Lobbying Activities (3)
Activity 1
Budget/Appropriations

Biodefense medical countermeasures research and development in the Defense Appropriations Act for FY 2025 (H.R. 8774, S. 4921) National Institutes of Health research on Long COVID in the Labor-HHS Appropriations Act for FY2025 National Institutes of Health research on cocaine abuse treatments in the Labor-HHS Appropriations Act for FY2025 (H.R. 9029, S. 4942)

Lobbyists (1)
  • STEVEN A WOLFE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Defense

Biodefense research in the National Defense Authorization Act for FY2025 (H.R. 8070 and S. 4638)

Lobbyists (1)
  • STEVEN A WOLFE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 3
Disaster Planning/Emergencies

Medical Countermeasures research, development and acquisition in the Pandemic All-Hazards Preparedness and Response Act (S. 2333).

Lobbyists (1)
  • STEVEN A WOLFE
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.